Expertise in
7
conditions

Andre M. Siqueira

Rio De Janeiro, RJ, BR 
Expertise in
7
conditions
Rio De Janeiro, RJ, BR 
OverviewLocationsClinical Research

Overview

Andre Siqueira practices in Rio De Janeiro, Brazil. Mr. Siqueira is highly rated in 7 conditions, according to our data. His top areas of expertise are Togaviridae Disease, Chikungunya, Malaria, and Dengue Fever.

His clinical research consists of co-authoring 113 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Rio De Janeiro, RJ, Brazil
Other Locations
Fiocruz, RJ, Brazil
Perdigao, MG, Brazil
Fortaleza, CE, Brazil
Fundação De Medicina Tropical Dr. Heitor Vieira Dourado, Boa Vista, Sao Jose Do Rio Preto, SP, Brazil
Manguinhos, RJ, Brazil
Eusebio, MG 61760000, Brazil
Nacional, RO, Brazil
Manaus, AM, Brazil
AM, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil
Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil
Enrollment Status: Completed
Publish Date: February 06, 2025
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate Efficacy and Safety in Healthcare Professionals of the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate Efficacy and Safety in Healthcare Professionals of the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac
Enrollment Status: Completed
Publish Date: February 15, 2024
Intervention Type: Biological
Study Drug: Inactivated COVID-19 Vaccine
Study Phase: Phase 3
Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Immunogenicity of the Dengue 1, 2, 3, 4 (Attenuated) Vaccine From Instituto Butantan
Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Immunogenicity of the Dengue 1, 2, 3, 4 (Attenuated) Vaccine From Instituto Butantan
Enrollment Status: Active_not_recruiting
Publish Date: February 15, 2024
Intervention Type: Other, Biological
Study Drug: Dengue 1,2,3,4 (Attenuated) Vaccine
Study Phase: Phase 3
View 2 Less Clinical Trials

112 Total Publications

Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE).
Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE).
Journal: The Lancet. Infectious diseases
Published: June 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Siqueira's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile